These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 20091535)

  • 1. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter Posthumous EE
    Cochrane Database Syst Rev; 2010 Jan; (1):CD002967. PubMed ID: 20091535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002967. PubMed ID: 16437448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
    Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD002967. PubMed ID: 20393934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
    Arch Intern Med; 2003 Nov; 163(21):2594-602. PubMed ID: 14638559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
    van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
    J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
    Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
    Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
    Inzucchi SE; Lipska KJ; Mayo H; Bailey CJ; McGuire DK
    JAMA; 2014 Dec 24-31; 312(24):2668-75. PubMed ID: 25536258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactic acidosis induced by metformin: incidence, management and prevention.
    Lalau JD
    Drug Saf; 2010 Sep; 33(9):727-40. PubMed ID: 20701406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes.
    Lee EY; Hwang S; Lee YH; Lee SH; Lee YM; Kang HP; Han E; Lee W; Lee BW; Kang ES; Cha BS; Lee HC
    Yonsei Med J; 2017 Mar; 58(2):312-318. PubMed ID: 28120561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Traditional contraindications to the use of metformin -- more harmful than beneficial?].
    Holstein A; Egberts EH
    Dtsch Med Wochenschr; 2006 Jan; 131(3):105-10. PubMed ID: 16418951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case risk study of lactic acidosis risk by metformin use in type 2 diabetes mellitus tuberculosis coinfection patients.
    Novita BD; Pranoto A; Wuryani ; Soediono EI; Mertaniasih NM
    Indian J Tuberc; 2018 Jul; 65(3):252-256. PubMed ID: 29933869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
    Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
    Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse event notifications implicating metformin with lactic acidosis in Australia.
    Huang W; Castelino RL; Peterson GM
    J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
    Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
    Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory-Confirmed Metformin-Associated Lactic Acidosis.
    Nestor C; Nasim S; Coyle N; Canavan C
    Ir Med J; 2019 Sep; 112(8):992. PubMed ID: 31650826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.
    Aharaz A; Pottegård A; Henriksen DP; Hallas J; Beck-Nielsen H; Lassen AT
    PLoS One; 2018; 13(5):e0196122. PubMed ID: 29738540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study.
    Kamber N; Davis WA; Bruce DG; Davis TM
    Med J Aust; 2008 Apr; 188(8):446-9. PubMed ID: 18429709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metformin-associated lactic acidosis precipitated by acute renal failure].
    Pertek JP; Vidal S; Mariot J; Galy-Floc'h M; Azoulay E
    Ann Fr Anesth Reanim; 2003 May; 22(5):457-60. PubMed ID: 12831972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.